{"id":"https://openalex.org/W4366243076","doi":"https://doi.org/10.1089/vbz.2022.0050","title":"Epidemiology of Lyme Borreliosis in France in Primary Care and Hospital Settings, 2010\u20132019","display_name":"Epidemiology of Lyme Borreliosis in France in Primary Care and Hospital Settings, 2010\u20132019","publication_year":2023,"publication_date":"2023-04-01","ids":{"openalex":"https://openalex.org/W4366243076","doi":"https://doi.org/10.1089/vbz.2022.0050","pmid":"https://pubmed.ncbi.nlm.nih.gov/37071406","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10122229"},"language":"en","primary_location":{"id":"doi:10.1089/vbz.2022.0050","doi":"https://doi.org/10.1089/vbz.2022.0050","is_oa":true,"landing_page_url":"https://doi.org/10.1089/vbz.2022.0050","pdf_url":"https://www.liebertpub.com/doi/pdf/10.1089/vbz.2022.0050?download=true","source":{"id":"https://openalex.org/S11075000","display_name":"Vector-Borne and Zoonotic Diseases","issn_l":"1530-3667","issn":["1530-3667","1557-7759"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vector-Borne and Zoonotic Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.liebertpub.com/doi/pdf/10.1089/vbz.2022.0050?download=true","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049882196","display_name":"Charles Nuttens","orcid":"https://orcid.org/0000-0001-6288-8023","observed_orcids":["https://orcid.org/0000-0001-6288-8023"]},"institutions":[{"id":"https://openalex.org/I4210118061","display_name":"Pfizer (France)","ror":"https://ror.org/02c9yny10","country_code":"FR","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210118061"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Charles Nuttens","raw_affiliation_strings":["Vaccine Medical Development, Scientific and Clinical Affairs, Pfizer SAS, Paris, France"],"raw_orcid":"https://orcid.org/0000-0001-6288-8023","affiliations":[{"raw_affiliation_string":"Vaccine Medical Development, Scientific and Clinical Affairs, Pfizer SAS, Paris, France","institution_ids":["https://openalex.org/I4210118061"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037920967","display_name":"Antoine Bessou","orcid":"https://orcid.org/0009-0000-8770-426X","observed_orcids":["https://orcid.org/0009-0000-8770-426X"]},"institutions":[{"id":"https://openalex.org/I4210144377","display_name":"IQVIA (France)","ror":"https://ror.org/0394bpd20","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210108991","https://openalex.org/I4210144377"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Antoine Bessou","raw_affiliation_strings":["IQVIA Op\u00e9rations France, Courbevoie, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IQVIA Op\u00e9rations France, Courbevoie, France","institution_ids":["https://openalex.org/I4210144377"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105036661","display_name":"St\u00e9phanie Duret","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210144377","display_name":"IQVIA (France)","ror":"https://ror.org/0394bpd20","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210108991","https://openalex.org/I4210144377"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"St\u00e9phanie Duret","raw_affiliation_strings":["IQVIA Op\u00e9rations France, Courbevoie, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IQVIA Op\u00e9rations France, Courbevoie, France","institution_ids":["https://openalex.org/I4210144377"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008999192","display_name":"Jozica Skufca","orcid":"https://orcid.org/0000-0001-8493-5046","observed_orcids":["https://orcid.org/0000-0001-8493-5046"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jozica Skufca","raw_affiliation_strings":["Pharmacovigilance and Epidemiology Services, P95, Leuven, Belgium"],"raw_orcid":"https://orcid.org/0000-0001-8493-5046","affiliations":[{"raw_affiliation_string":"Pharmacovigilance and Epidemiology Services, P95, Leuven, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Emmanuelle Blanc","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118061","display_name":"Pfizer (France)","ror":"https://ror.org/02c9yny10","country_code":"FR","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210118061"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Emmanuelle Blanc","raw_affiliation_strings":["Vaccine Medical Development, Scientific and Clinical Affairs, Pfizer SAS, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vaccine Medical Development, Scientific and Clinical Affairs, Pfizer SAS, Paris, France","institution_ids":["https://openalex.org/I4210118061"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051845277","display_name":"Andreas Pilz","orcid":"https://orcid.org/0000-0002-6394-3845","observed_orcids":["https://orcid.org/0000-0002-6394-3845"]},"institutions":[{"id":"https://openalex.org/I4210157852","display_name":"Pfizer (Austria)","ror":"https://ror.org/04jtnvj04","country_code":"AT","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210157852"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Andreas Pilz","raw_affiliation_strings":["Vaccine Medical Development, Scientific and Clinical Affairs, Pfizer Corporation Austria, Vienna, Austria"],"raw_orcid":"https://orcid.org/0000-0002-6394-3845","affiliations":[{"raw_affiliation_string":"Vaccine Medical Development, Scientific and Clinical Affairs, Pfizer Corporation Austria, Vienna, Austria","institution_ids":["https://openalex.org/I4210157852"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070628953","display_name":"Bradford D. Gessner","orcid":"https://orcid.org/0000-0002-6216-7194","observed_orcids":["https://orcid.org/0000-0002-6216-7194"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bradford D. Gessner","raw_affiliation_strings":["Vaccine Medical Development, Scientific and Clinical Affairs, Pfizer, Inc., Collegeville, Pennsylvania, USA"],"raw_orcid":"https://orcid.org/0000-0002-6216-7194","affiliations":[{"raw_affiliation_string":"Vaccine Medical Development, Scientific and Clinical Affairs, Pfizer, Inc., Collegeville, Pennsylvania, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039120767","display_name":"Jean\u2010Fran\u00e7ois Faucher","orcid":"https://orcid.org/0000-0002-1629-1194","observed_orcids":["https://orcid.org/0000-0002-1629-1194"]},"institutions":[{"id":"https://openalex.org/I4210118469","display_name":"Centre Hospitalier Universitaire de Limoges","ror":"https://ror.org/01tc2d264","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210118469"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-Fran\u00e7ois Faucher","raw_affiliation_strings":["Service des maladies infectieuses et tropicales, CHU de Limoges, Limoges, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service des maladies infectieuses et tropicales, CHU de Limoges, Limoges, France","institution_ids":["https://openalex.org/I4210118469"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042131677","display_name":"James H. Stark","orcid":"https://orcid.org/0000-0002-0728-876X","observed_orcids":["https://orcid.org/0000-0002-0728-876X"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James H. Stark","raw_affiliation_strings":["Vaccine Medical Development, Scientific and Clinical Affairs, Pfizer, Inc., Collegeville, Pennsylvania, USA"],"raw_orcid":"https://orcid.org/0000-0002-0728-876X","affiliations":[{"raw_affiliation_string":"Vaccine Medical Development, Scientific and Clinical Affairs, Pfizer, Inc., Collegeville, Pennsylvania, USA","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5049882196"],"corresponding_institution_ids":["https://openalex.org/I4210118061"],"apc_list":null,"apc_paid":null,"fwci":3.8734,"has_fulltext":true,"cited_by_count":17,"citation_normalized_percentile":{"value":0.94364582,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"23","issue":"4","first_page":"221","last_page":"229"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10296","display_name":"Vector-borne infectious diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2405","display_name":"Parasitology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10296","display_name":"Vector-borne infectious diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2405","display_name":"Parasitology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11899","display_name":"Brucella: diagnosis, epidemiology, treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11819","display_name":"Data-Driven Disease Surveillance","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lyme-disease","display_name":"Lyme disease","score":1.0},{"id":"https://openalex.org/keywords/borrelia-burgdorferi","display_name":"Borrelia burgdorferi","score":0.8889999985694885},{"id":"https://openalex.org/keywords/incidence-trends","display_name":"incidence trends","score":0.8090000152587891},{"id":"https://openalex.org/keywords/hospitalization","display_name":"hospitalization","score":0.6489999890327454},{"id":"https://openalex.org/keywords/primary-care","display_name":"primary care","score":0.8339999914169312},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.8029999732971191},{"id":"https://openalex.org/keywords/age-distribution","display_name":"age distribution","score":0.6389999985694885},{"id":"https://openalex.org/keywords/adolescents","display_name":"adolescents","score":0.4519999921321869},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.8360000252723694},{"id":"https://openalex.org/keywords/regional-disparities","display_name":"regional disparities","score":0.531000018119812},{"id":"https://openalex.org/keywords/limousin","display_name":"Limousin","score":0.9010000228881836},{"id":"https://openalex.org/keywords/france","display_name":"France","score":0.6600000262260437}],"concepts":[{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.7789657115936279},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7632842659950256},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.6158645153045654},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.4823119640350342},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4821176528930664},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.47088557481765747},{"id":"https://openalex.org/C167704817","wikidata":"https://www.wikidata.org/wiki/Q7295548","display_name":"Rate ratio","level":3,"score":0.4548095762729645},{"id":"https://openalex.org/C149923435","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demography","level":1,"score":0.4205726385116577},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.3296603560447693},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.19339406490325928},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1144479513168335},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005602","descriptor_name":"France","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006760","descriptor_name":"Hospitalization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006761","descriptor_name":"Hospitals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008193","descriptor_name":"Lyme Disease","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D008193","descriptor_name":"Lyme Disease","qualifier_ui":"Q000662","qualifier_name":"veterinary","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011320","descriptor_name":"Primary Health Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1089/vbz.2022.0050","doi":"https://doi.org/10.1089/vbz.2022.0050","is_oa":true,"landing_page_url":"https://doi.org/10.1089/vbz.2022.0050","pdf_url":"https://www.liebertpub.com/doi/pdf/10.1089/vbz.2022.0050?download=true","source":{"id":"https://openalex.org/S11075000","display_name":"Vector-Borne and Zoonotic Diseases","issn_l":"1530-3667","issn":["1530-3667","1557-7759"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vector-Borne and Zoonotic Diseases","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10122229","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10122229","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10122229/pdf/vbz.2022.0050.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vector Borne Zoonotic Dis","raw_type":"Text"},{"id":"pmid:37071406","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37071406","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vector borne and zoonotic diseases (Larchmont, N.Y.)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1089/vbz.2022.0050","doi":"https://doi.org/10.1089/vbz.2022.0050","is_oa":true,"landing_page_url":"https://doi.org/10.1089/vbz.2022.0050","pdf_url":"https://www.liebertpub.com/doi/pdf/10.1089/vbz.2022.0050?download=true","source":{"id":"https://openalex.org/S11075000","display_name":"Vector-Borne and Zoonotic Diseases","issn_l":"1530-3667","issn":["1530-3667","1557-7759"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vector-Borne and Zoonotic Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4366243076.pdf","grobid_xml":"https://content.openalex.org/works/W4366243076.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W1787755944","https://openalex.org/W1914817624","https://openalex.org/W2002952652","https://openalex.org/W2033139226","https://openalex.org/W2061135116","https://openalex.org/W2123033778","https://openalex.org/W2123514835","https://openalex.org/W2141914159","https://openalex.org/W2547266688","https://openalex.org/W2611497427","https://openalex.org/W2791507665","https://openalex.org/W2884301964","https://openalex.org/W2920938899","https://openalex.org/W2985202241","https://openalex.org/W3031814359","https://openalex.org/W3204081094","https://openalex.org/W4296416927"],"related_works":["https://openalex.org/W2920938899","https://openalex.org/W2054552854","https://openalex.org/W4400678573","https://openalex.org/W4387943934","https://openalex.org/W2093125513","https://openalex.org/W4366237430","https://openalex.org/W7080188234","https://openalex.org/W1842765063","https://openalex.org/W4311757688","https://openalex.org/W4311739277"],"abstract_inverted_index":{"Introduction:":[0],"Lyme":[1],"borreliosis":[2],"(LB)":[3],"is":[4],"a":[5,122],"growing":[6],"public":[7],"health":[8,18],"concern":[9],"requiring":[10],"accurate":[11],"and":[12,31,45,73,114,140,186,191,213,239,250,265,272],"comprehensive":[13],"epidemiological":[14],"knowledge":[15],"to":[16,79,86,106,116,135,147],"inform":[17],"care":[19,30,98,153,211,249,271],"interventions.":[20],"This":[21,56],"study":[22,57],"compared":[23,155],"the":[24,36,74,81,111,119,175,198,240,244,258],"epidemiology":[25,83],"of":[26,43,52,94,260],"LB":[27,82,95,150],"in":[28,39,96,104,108,125,151,209,225,237,257],"primary":[29,97,152,210,248,270],"hospital":[32,76,251,273],"settings,":[33],"using":[34],"for":[35,110,118,246],"first":[37],"time":[38],"France":[40],"three":[41],"sources":[42],"data,":[44],"highlighted":[46],"specific":[47],"populations":[48],"at":[49],"higher":[50],"risk":[51],"developing":[53],"LB.":[54],"Methods:":[55],"analyzed":[58],"data":[59],"from":[60,84,100,133],"general":[61],"practitioner":[62],"networks":[63],"(":[64],"i.e":[65],".,":[66],"Sentinel":[67,112],"network,":[68],"Electronic":[69],"Medical":[70],"Records":[71],"[EMR])":[72],"national":[75],"discharge":[77],"database":[78],"describe":[80],"2010":[85],"2019.":[87],"Results:":[88],"The":[89,127],"average":[90,199],"annual":[91,128,200],"incidence":[92,159,201,263],"rates":[93,236],"increased":[99],"42.3":[101],"cases/100,000":[102],"population":[103],"2010\u20132012":[105],"83.0/100,000":[107],"2017\u20132019":[109],"Network":[113],"42.7/100,000":[115],"74.6/100,000":[117],"EMR,":[120],"following":[121],"marked":[123],"rise":[124],"2016.":[126],"hospitalization":[129],"rate":[130,160,202],"remained":[131],"stable":[132],"2012":[134],"2019":[136],"fluctuating":[137],"between":[138,269],"1.6":[139],"1.8":[141],"hospitalizations/100,000.":[142],"Women":[143],"were":[144,167,243],"more":[145],"likely":[146],"present":[148],"with":[149,156,174],"setting":[154],"men":[157,166],"(male-to-female":[158],"ratio":[161],"[IRR]":[162],"=":[163,172,184,194],"0.92),":[164],"whereas":[165],"predominant":[168,266],"among":[169,178,204,217],"hospitalizations":[170],"(IRR":[171,183,193],"1.4),":[173],"largest":[176],"discordance":[177],"adolescents":[179],"aged":[180,188,206,214,227],"10\u201314":[181],"years":[182,190,208,216,231],"1.8)":[185],"adults":[187],"80":[189],"older":[192],"2.5).":[195],"In":[196],"2017\u20132019,":[197],"peaked":[203],"persons":[205],"60\u201369":[207],"(>125/100,000)":[212],"70\u201379":[215],"hospitalized":[218],"patients":[219],"(3.4/100,000).":[220],"A":[221],"second":[222],"peak":[223],"occurred":[224],"children":[226],"0\u20134":[228],"or":[229],"5\u20139":[230],"depending":[232],"on":[233],"sources.":[234],"Incidence":[235],"Limousin":[238],"north-eastern":[241],"regions":[242],"highest":[245],"both":[247],"settings.":[252],"Conclusions:":[253],"Analyses":[254],"showed":[255],"disparities":[256],"evolution":[259],"incidence,":[261],"sex-specific":[262],"rates,":[264],"age":[267],"groups":[268],"settings":[274],"that":[275],"merit":[276],"further":[277],"exploration.":[278]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2023-04-20T00:00:00"}